Y-Intercept (HK)’s Regeneron Pharmaceuticals REGN Stock Holding History

Y-Intercept (HK)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Buy	+3,198	New	+$2.18M	0.04%	704
2025 Q4	–	Sell	-10,318	Closed	-$5.8M	–	1924
2025 Q3	$5.8M	Sell	10,318 -24,556	-70%	-$13.9M	0.14%	165
2025 Q2	$18.3M	Buy	34,874 +25,170	+259%	+$14M	0.45%	12
2025 Q1	$6.15M	Sell	9,704 -1,821	-16%	-$1.25M	0.42%	37
2024 Q4	$8.21M	Buy	11,525 +2,100	+22%	+$1.76M	0.55%	12
2024 Q3	$9.91M	Buy	+9,425	New	+$10.5M	0.61%	12
2024 Q2	–	Sell	-1,967	Closed	-$1.89M	–	1834
2024 Q1	$1.89M	Sell	1,967 -1,218	-38%	-$1.16M	0.14%	181
2023 Q4	$2.8M	Buy	+3,185	New	+$2.62M	0.26%	75
2023 Q3	–	Sell	-2,221	Closed	-$1.6M	–	1500
2023 Q2	$1.6M	Buy	+2,221	New	+$1.71M	0.17%	151
2023 Q1	–	Sell	-1,107	Closed	-$799K	–	1474
2022 Q4	$799K	Buy	+1,107	New	+$817K	0.12%	267
2022 Q3	–	Sell	-847	Closed	-$501K	–	1220
2022 Q2	$501K	Sell	847 -1,010	-54%	-$657K	0.07%	426
2022 Q1	$1.3M	Buy	+1,857	New	+$1.17M	0.3%	71
2021 Q4	–	Sell	-4,133	Closed	-$2.5M	–	832
2021 Q3	$2.5M	Sell	4,133 -73	-2%	-$45.3K	0.45%	33
2021 Q2	$2.35M	Buy	+4,206	New	+$2.13M	0.6%	16

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Y-Intercept (HK)'s REGN Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 3,198 shares worth $1.99M. The stake represents 0.04% of the portfolio and ranks #704 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in REGN as recently as Q3 2025.

Y-Intercept (HK) first reported a position in REGN in Q2 2021 and has held it in 14 quarters since. The position peaked at $18.3M in Q2 2025. 361 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Y-Intercept (HK) held 3,198 shares of Regeneron Pharmaceuticals worth $1.99M as of Q2 2026.
Regeneron Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
Regeneron Pharmaceuticals made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #704 holding.
Y-Intercept (HK) first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 14 quarters since.
Y-Intercept (HK)'s Regeneron Pharmaceuticals position peaked at $18.3M in Q2 2025.
361 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.